Literature DB >> 6348951

Clinical pharmacology and toxicology of cyclophosphamide: emphasis on use in rheumatic diseases.

J Kovarsky.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6348951     DOI: 10.1016/0049-0172(83)90016-1

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


× No keyword cloud information.
  13 in total

Review 1.  Combination therapy in autoimmune disease: vasculitis.

Authors:  D Carruthers; P Bacon
Journal:  Springer Semin Immunopathol       Date:  2001

2.  Multiple sclerosis review.

Authors:  Marvin M Goldenberg
Journal:  P T       Date:  2012-03

3.  Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms.

Authors:  Amer Awad; Olaf Stüve
Journal:  Ther Adv Neurol Disord       Date:  2009-11       Impact factor: 6.570

Review 4.  Optimisation of cyclophosphamide therapy in systemic vasculitis.

Authors:  R Richmond; T W McMillan; R A Luqmani
Journal:  Clin Pharmacokinet       Date:  1998-01       Impact factor: 6.447

Review 5.  Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis.

Authors:  A Nandoskar; J Raffel; A S Scalfari; T Friede; R S Nicholas
Journal:  Drugs       Date:  2017-05       Impact factor: 9.546

6.  Wegener's granulomatosis.

Authors:  K E Sack
Journal:  West J Med       Date:  1989-03

Review 7.  Immunosuppressive drugs and corticosteroids in the treatment of rheumatoid arthritis.

Authors:  M Arnold; L Schrieber; P Brooks
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

Review 8.  Cyclophosphamide-based combination therapies for autoimmunity.

Authors:  Paola Perini; Massimiliano Calabrese; Luciano Rinaldi; Paolo Gallo
Journal:  Neurol Sci       Date:  2008-09       Impact factor: 3.307

9.  Comparison of antibody, antigen, and metabolite assays in rat models of systemic and gastrointestinal candidiasis.

Authors:  R A Greenfield; D L Troutt; R C Rickard; D H Altmiller
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

10.  Antigen and lymphopenia-driven donor T cells are differentially diminished by post-transplantation administration of cyclophosphamide after hematopoietic cell transplantation.

Authors:  Duncan Ross; Monica Jones; Krishna Komanduri; Robert B Levy
Journal:  Biol Blood Marrow Transplant       Date:  2013-06-29       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.